September 2004

Atlantic Blue Cross: Directing patient-physician decision making

Atlantic Blue Cross stepped out of the boardroom and into the rheumatologists' office this year an action that made Enbrel the first line treatment over Remicade for people with inflammatory arthritis.

Comments

no comments so far

Leave a Comment

You must register and log-in to add a comment.

Comments are moderated and generally will be posted if they are on-topic and not abusive.

become a member - add your voice sign up to our newsletter - be informed